Team designs molecule that could be first antidote for carbon monoxide poisoning

December 7, 2016

Researchers from the University of Pittsburgh School of Medicine and UPMC have engineered a protein that reverses carbon monoxide (CO) poisoning in mice, a discovery that could potentially lead to the creation of the first antidote in humans to the often deadly poisoning, according to research published today in the journal Science Translational Medicine.

CO poisoning is responsible for more than 50,000 in the United States annually, and is one of the leading global causes of poisoning death. A colorless, odorless gas, CO is extremely effective at replacing in hemoglobin, the carrying protein in blood. CO exposure also results in debilitating effects on the body and the brain, including cognitive deficits that in some cases can persist months or years after a poisoning event.

"Despite being the most common poisoning worldwide, we still do not have an effective antidote for CO exposure," said Mark T. Gladwin, M.D., chair of medicine, Pitt School of Medicine, Dr. Jack D. Myers Professor of Internal Medicine, and director of the Pittsburgh Heart, Lung, Blood and Vascular Medicine Institute. "Our protein is extraordinarily effective at scavenging CO from the blood, and could potentially prove to be a significant advance in the treatment of CO poisoning."

Current treatment options for CO poisoning—administering 100 percent oxygen or using a pressurized to administer oxygen at greater than normal air pressure—focus on trying to replace CO in blood with oxygen as quickly as possible. However, both these treatments are only moderately effective. Moreover, transporting patients to a hyperbaric chamber requires a significant amount of time, and many poisoned patients may not be stable enough for this therapy.

When studying neuroglobin (Ngb), a hemoglobin-like protein present in the brain, Gladwin and his team discovered it could bind CO with an unusually high affinity. Based on prior knowledge of how the protein works, researchers engineered a mutant version of the protein, called Ngb H64Q, that was an even better scavenger of CO.

In a purified sample of red blood cells infused with CO, they found that Ngb H64Q was 1,200 times faster at forcing CO to release itself from being bound to hemoglobin than just air alone. When tested in a mouse model of non-lethal CO poisoning, they found that Ngb H64Q was significantly better at removing CO from hemoglobin than 100-percent oxygen treatment. The normal half-life of CO in humans after poisoning (time it takes for half of the CO to be eliminated from the body) is 320 minutes, and even with 100-percent oxygen therapy, that time is 74 minutes. With the antidote therapy, the CO half-life was reduced to only 23 seconds.

The video will load shortly.
Credit: University of Pittsburgh Medical Center

In a mouse model with lethal levels of CO , seven out of eight mice treated with Ngb H64Q (87.5 percent) survived the duration of the experiment, while 10 percent or less survived in the control groups. Additionally, the antidote restored blood pressure and improved the amount of oxygen that was present in tissues, suggesting that Ngb H64Q works by scavenging CO from hemoglobin and allowing oxygen to bind in its place, thus restoring normal oxygen delivery.

Importantly, CO bound to Ngb H64Q was detected in the urine of mice shortly after treatment, which indicated that the rodents were able to excrete the antidote from the body without any major toxic effects.

"If approved, this antidote could be rapidly administered to victims in the field, eliminating costly delays that occur with current treatment options," Gladwin said. "We still need extensive safety and efficacy testing before an is available on the shelf, but our early results are very promising."

Researchers plan to scale up their safety and efficacy testing in animal models and hope to advance to clinical trials within the next few years.

Explore further: Less than a quarter of hospitals stock antidotes required for immediate use

More information: "Five-coordinate H64Q neuroglobin as a ligand-trap antidote for carbon monoxide poisoning," Science Translational Medicine, stm.sciencemag.org/lookup/doi/ … scitranslmed.aah6571

Related Stories

Less than a quarter of hospitals stock antidotes required for immediate use

November 18, 2015
Less than a quarter of hospitals in England, Wales and Northern Ireland stock all of the recommended antidotes for immediate use in emergency departments, reveals an audit published in the online journal the European Journal ...

Hyperbaric oxygen chambers aren't cure-alls, FDA warns

August 22, 2013
(HealthDay)—Despite claims on some websites, there is no evidence that hyperbaric oxygen therapy cures or is an effective treatment for diseases such as cancer, autism, diabetes or other diseases, the U.S. Food and Drug ...

COPD patients with moderately low oxygen deficiencies don't benefit from long-term oxygen

October 26, 2016
A newly published study of people with chronic obstructive pulmonary disease (COPD) concludes that long-term supplemental oxygen treatment results in little or no change in time to death, time to first hospitalizations or ...

Recommended for you

Hibernating ground squirrels provide clues to new stroke treatments

November 17, 2017
In the fight against brain damage caused by stroke, researchers have turned to an unlikely source of inspiration: hibernating ground squirrels.

Age and gut bacteria contribute to multiple sclerosis disease progression

November 17, 2017
Researchers at Rutgers Robert Wood Johnson Medical School published a study suggesting that gut bacteria at young age can contribute to multiple sclerosis (MS) disease onset and progression.

Molecular guardian defends cells, organs against excess cholesterol

November 16, 2017
A team of researchers at the Harvard T. H. Chan School of Public Health has illuminated a critical player in cholesterol metabolism that acts as a molecular guardian in cells to help maintain cholesterol levels within a safe, ...

Prototype ear plug sensor could improve monitoring of vital signs

November 16, 2017
Scientists have developed a sensor that fits in the ear, with the aim of monitoring the heart, brain and lungs functions for health and fitness.

Ancient enzyme could boost power of liquid biopsies to detect and profile cancers

November 16, 2017
Scientists are developing a set of medical tests called liquid biopsies that can rapidly detect the presence of cancers, infectious diseases and other conditions from only a small blood sample. Researchers at The University ...

FDA to crack down on risky stem cell offerings

November 16, 2017
U.S. health authorities announced plans Thursday to crack down on doctors pushing stem cell procedures that pose the gravest risks to patients amid an effort to police a burgeoning medical field that previously has received ...

3 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

qquax
not rated yet Dec 07, 2016
This needs to be fast tracked for patients exposed to lethal doses of CO.
aksdad
not rated yet Dec 07, 2016
Get Ngb H64Q to hospitals and emergency services immediately with the caveat that it's an experimental medication requiring a signed release by a patient or someone willing to accept responsibility for an incapacitated patient. It won't take long to develop a large study population. Do follow-up studies to determine side effects. Meanwhile the antidote can be saving lives.

That's your fast-track. Why is that so hard?
Whydening Gyre
not rated yet Dec 07, 2016
Get Ngb H64Q to hospitals and emergency services immediately with the caveat that it's an experimental medication requiring a signed release by a patient or someone willing to accept responsibility for an incapacitated patient. It won't take long to develop a large study population. Do follow-up studies to determine side effects. Meanwhile the antidote can be saving lives.

That's your fast-track. Why is that so hard?

They kinda did that with Lasik eye surgery. Mine didn't turn out like they said it would.
...AND they didn't have to pay me my money back...
Fast-tracking under those proviso's isn't hard at all...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.